LM-108 in Combination With Toripalimab Versus Paclitaxel Injection for the Treatment of Subjects With CCR8-Positive Gastric and Gastroesophageal Junction Adenocarcinoma

Clinical trial NCT07362186 · RECRUITING

Trial details

NCT number: NCT07362186
Sponsor: LaNova Medicines Limited
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Locally Advanced or Metastatic GC and GCJ Adenocarcinoma

Start date: 2026-04-30
Primary completion: 2028-08-17
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.